Zobrazeno 1 - 6
of 6
pro vyhledávání: '"van Bochove GG"'
Autor:
Thijssen R, Ter Burg J, van Bochove GG, de Rooij MF, Kuil A, Jansen MH, Kuijpers TW, Baars JW, Virone-Oddos A, Spaargaren M, Egile C, van Oers MH, Eldering E, Kersten MJ, Kater AP
Publikováno v:
Leukemia [Leukemia] 2016 Sep; Vol. 30 (9), pp. 1963.
Autor:
Thijssen R; Department of Experimental Immunology and Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;, Ter Burg J; Department of Experimental Immunology and Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;, Garrick B; Celgene, San Francisco, CA;, van Bochove GG; Department of Experimental Immunology and Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;, Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;, Rodríguez MS; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain;, Michot JM; Department of Hematology, Institut Gustave Roussy, Villejuif, France;, Hallek M; Department of Hematology, University Hospital, Cologne, Germany;, Eichhorst B; Department of Hematology, University Hospital, Cologne, Germany;, Reinhardt HC; Department of Hematology, University Hospital, Cologne, Germany;, Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;, Derks IA; Department of Experimental Immunology and., van Kampen RJ; Orbis Medisch Centrum, Sittard, The Netherlands; and., Hege K; Celgene, San Francisco, CA;, Kersten MJ; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Lymphoma and Myeloma Center Amsterdam, The Netherlands., Trowe T; Celgene, San Francisco, CA;, Filvaroff EH; Celgene, San Francisco, CA;, Eldering E; Department of Experimental Immunology and Lymphoma and Myeloma Center Amsterdam, The Netherlands., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Lymphoma and Myeloma Center Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2016 Jul 28; Vol. 128 (4), pp. 574-83. Date of Electronic Publication: 2016 May 27.
Autor:
Thijssen R; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Ter Burg J; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., van Bochove GG; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., de Rooij MF; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kuil A; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Jansen MH; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kuijpers TW; Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.; Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands., Baars JW; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Virone-Oddos A; Cancer Biology, Sanofi Oncology, Vitry/Seine, France., Spaargaren M; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands.; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Egile C; Translational Medicine, Sanofi Oncology, Vitry/Seine, France., van Oers MH; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Kersten MJ; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2016 Feb; Vol. 30 (2), pp. 337-45. Date of Electronic Publication: 2015 Sep 04.
Autor:
Pascutti MF; Department of Experimental Immunology., Jak M, Tromp JM, Derks IA, Remmerswaal EB, Thijssen R, van Attekum MH, van Bochove GG, Luijks DM, Pals ST, van Lier RA, Kater AP, van Oers MH, Eldering E
Publikováno v:
Blood [Blood] 2013 Oct 24; Vol. 122 (17), pp. 3010-9. Date of Electronic Publication: 2013 Sep 06.
Autor:
Jak M; Department of Hematology, Academic Medical Centre, Amsterdam, The Netherlands. m.jak@amc.uva.nl, van Bochove GG, Reits EA, Kallemeijn WW, Tromp JM, Umana P, Klein C, van Lier RA, van Oers MH, Eldering E
Publikováno v:
Blood [Blood] 2011 Nov 10; Vol. 118 (19), pp. 5178-88. Date of Electronic Publication: 2011 Sep 26.
Autor:
Jak M; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands. m.jak@amc.uva.nl, van Bochove GG, van Lier RA, Eldering E, van Oers MH
Publikováno v:
Leukemia [Leukemia] 2011 Jun; Vol. 25 (6), pp. 968-78. Date of Electronic Publication: 2011 Mar 15.